Mode
Text Size
Log in / Sign up

Narrative review proposes combining rTMS and mindfulness for treatment-resistant depression

Narrative review proposes combining rTMS and mindfulness for treatment-resistant depression
Photo by ClinicalPulse / Unsplash
Key Takeaway
Consider the proposed rTMS-mindfulness combination for TRD as a theoretical hypothesis requiring clinical trial validation.

A narrative review examined the theoretical basis for combining repetitive Transcranial Magnetic Stimulation (rTMS) with Mindfulness-Based Interventions (MBI) as a potential treatment for patients with treatment-resistant depression. The review did not analyze specific clinical trials or report a sample size, setting, comparator, or primary outcome. Instead, it proposed that the combination may enhance therapeutic outcomes through additive or synergistic effects on brain network reorganization, based on theoretical neurobiological mechanisms.

No specific results, effect sizes, absolute numbers, p-values, or confidence intervals were reported for this proposed combination. The review did not provide data on safety, adverse events, serious adverse events, discontinuations, or tolerability for the combined approach.

Key limitations include reliance on limited evidence from analogous therapeutic combinations rather than direct clinical trials of this specific intervention. The authors note that synergistic effects are plausible but not proven, and the evidence is promising but not conclusive. The practice relevance is limited to proposing a novel approach for future clinical trial design, as no clinical recommendations can be made from this theoretical review.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Treatment-resistant depression (TRD) poses a significant challenge, with many patients failing to achieve remission with conventional therapies. While repetitive Transcranial Magnetic Stimulation (rTMS) is an established and effective neuromodulatory treatment for TRD, a notable proportion of patients do not fully respond. Despite the clinical utility of rTMS, response variability remains a significant barrier to treatment optimization. We propose that this variability may be driven, in part, by fluctuations in baseline network configuration and momentary brain states. This motivates the investigation of behavioral state manipulation as a means to prime neural circuits for enhanced receptivity to neuromodulation. This mini-review proposes that combining TMS with adjunctive, short-duration mental practices, specifically Mindfulness Based Interventions (MBI), may enhance therapeutic outcomes. Given that both TMS and mindfulness converge on modulating brain networks regulating emotions, attention and self-referential processes, it is plausible that their concurrent or sequential use could yield additive or even synergistic effects on network reorganization. We will explore the theoretical neurobiological mechanisms that may support a potential synergistic or additive effect and synthesize the limited but promising evidence from analogous therapeutic combinations to argue for the clinical viability of this novel approach. This review aims to: (1) Summarize the shared network targets (DMN, CEN, and SN) of rTMS and mindfulness; (2) Propose a state-dependent synergy model for their integration; and (3) Synthesize existing evidence to guide future clinical trial design.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.